{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:06Z","timestamp":1787440926542,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018780","name":"Government of Andalusia Andalusian Health Service","doi-asserted-by":"publisher","award":["B-0042-2020"],"award-info":[{"award-number":["B-0042-2020"]}],"id":[{"id":"10.13039\/501100018780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI22\/001464"],"award-info":[{"award-number":["PI22\/001464"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020863","name":"Hospital Universitario Virgen del Roc\u00edo","doi-asserted-by":"publisher","award":["0019-N- 23"],"award-info":[{"award-number":["0019-N- 23"]}],"id":[{"id":"10.13039\/100020863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020863","name":"Hospital Universitario Virgen del Roc\u00edo","doi-asserted-by":"publisher","award":["PRJNA1364791"],"award-info":[{"award-number":["PRJNA1364791"]}],"id":[{"id":"10.13039\/100020863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["JR20\/00023"],"award-info":[{"award-number":["JR20\/00023"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["CP24\/00137"],"award-info":[{"award-number":["CP24\/00137"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijantimicag.2026.107848","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:38:28Z","timestamp":1779583108000},"page":"107848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Essential role of the leucine-293 for the AmpC \u03b2-lactamase in the resistance to cefepime, cefiderocol, and new \u03b2-lactams\/\u03b2-lactamase inhibitor combinations in Enterobacter hormaechei"],"prefix":"10.1016","volume":"67","author":[{"given":"Marta","family":"Rodr\u00edguez-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8567-7083","authenticated-orcid":false,"given":"Enrique","family":"Alan\u00eds-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1774-2580","authenticated-orcid":false,"given":"Carlos S.","family":"Casimiro-Soriguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2899-7207","authenticated-orcid":false,"given":"Jos\u00e9 Manuel","family":"Ortiz de la Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1381-1510","authenticated-orcid":false,"given":"Carmen","family":"Soto-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Dorado Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3635-4930","authenticated-orcid":false,"given":"Jos\u00e9 Antonio","family":"Lepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6373-9724","authenticated-orcid":false,"given":"\u00c1ngel","family":"Rodr\u00edguez-Villodres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107848_bib0001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jinf.2014.08.012","article-title":"Bacteremia is associated with excess long-term mortality: a 12-year population-based cohort study","volume":"70","author":"Nielsen","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0002","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00002-19","article-title":"Enterobacter spp.: update on taxonomy, clinical aspects, and emerging antimicrobial resistance","volume":"32","author":"Davin-Regli","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0003","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America guidance on the treatment of AmpC \u03b2-lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0004","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/jac\/dkaf122","article-title":"Impact of the inoculum effect on cefepime activity against AmpC-hyperproducing Enterobacter spp.: insights into resistance mechanisms","volume":"80","author":"Rodr\u00edguez-Villodres","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0005","doi-asserted-by":"crossref","first-page":"ofad034","DOI":"10.1093\/ofid\/ofad034","article-title":"High-dose cefepime vs carbapenems for bacteremia caused by Enterobacterales with moderate to high risk of clinically significant AmpC \u03b2-lactamase production","volume":"10","author":"Kunz Coyne","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00928-25","article-title":"Comparison between cefepime and carbapenem therapy for deep-seated AmpC-producing Enterobacterales infections: a propensity-weighted retrospective cohort study","volume":"69","author":"Slain","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0007","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance. 2017. https:\/\/www.eucast.org\/bacteria\/important-additional-information\/resistance-detection\/. Accessed May 2, 2025."},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0008","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. 2025. https:\/\/www.eucast.org\/bacteria\/clinical-breakpoints-and-interpretation\/clinical-breakpoint-tables\/. Accessed October 2, 2025."},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02161-21","article-title":"In vitro activity of cefepime-taniborbactam against carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates recovered in Spain","volume":"66","author":"Hern\u00e1ndez-Garc\u00eda","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0010","doi-asserted-by":"crossref","first-page":"8365","DOI":"10.1038\/srep08365","article-title":"RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes","volume":"5","author":"Brettin","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01841-19","article-title":"A standard numbering scheme for class C \u03b2-lactamases","volume":"64","author":"Mack","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0012","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1089\/mdr.2021.0180","article-title":"Mechanisms of reduced susceptibility to cefiderocol among isolates from the CREDIBLE-CR and APEKS-NP clinical trials","volume":"28","author":"Nordmann","year":"2022","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0013","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/mdr.2021.0095","article-title":"Defining baseline mechanisms of cefiderocol resistance in the Enterobacterales","volume":"28","author":"Simner","year":"2022","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0014","doi-asserted-by":"crossref","first-page":"W295","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0015","article-title":"Boltz-2: towards accurate and efficient binding affinity prediction (Preprint)","author":"Passaro","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0016","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/jac\/dkr423","article-title":"Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo","volume":"67","author":"Rodr\u00edguez-Mart\u00ednez","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00198-20","article-title":"Structural basis of reduced susceptibility to ceftazidime-avibactam and cefiderocol in Enterobacter cloacae due to AmpC R2 loop deletion","volume":"64","author":"Kawai","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0018","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1574-6968.2001.tb10519.x","article-title":"Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate","volume":"195","author":"Barnaud","year":"2001","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2026.107848_bib0019","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/cid\/ciaa355","article-title":"Clinical Evolution of AmpC-mediated ceftazidime-avibactam and cefiderocol resistance in Enterobacter cloacae complex following exposure to cefepime","volume":"71","author":"Shields","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926001378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:42:14Z","timestamp":1787438534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926001378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0924857926001378"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107848","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Essential role of the leucine-293 for the AmpC \u03b2-lactamase in the resistance to cefepime, cefiderocol, and new \u03b2-lactams\/\u03b2-lactamase inhibitor combinations in Enterobacter hormaechei","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107848"}}